JPMorgan Chase & Co’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.1K | Sell |
2,880
-175
| -6% | -$1.59K | ﹤0.01% | 5270 |
|
|
2025
Q1 | $29.1K | Sell |
3,055
-4,006
| -57% | -$38.2K | ﹤0.01% | 5178 |
|
|
2024
Q4 | $79.3K | Buy |
7,061
+4,465
| +172% | +$50.1K | ﹤0.01% | 4852 |
|
|
2024
Q3 | $37.3K | Buy |
2,596
+48
| +2% | +$690 | ﹤0.01% | 5064 |
|
|
2024
Q2 | $44K | Sell |
2,548
-3,124
| -55% | -$53.9K | ﹤0.01% | 4943 |
|
|
2024
Q1 | $113K | Buy |
5,672
+94
| +2% | +$1.87K | ﹤0.01% | 4688 |
|
|
2023
Q4 | $58.7K | Buy |
5,578
+5,574
| +139,350% | +$58.6K | ﹤0.01% | 4968 |
|
|
2023
Q3 | $35 | Hold |
4
| – | – | ﹤0.01% | 6097 |
|
|
2023
Q2 | $39 | Hold |
4
| – | – | ﹤0.01% | 5849 |
|
|
2023
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 5928 |
|
|
2022
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 5714 |
|
|
2022
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 5631 |
|
|
2022
Q2 | $0 | Sell |
4
-1,918
| -100% | – | ﹤0.01% | 5712 |
|
|
2022
Q1 | $38K | Buy |
1,922
+366
| +24% | +$7.24K | ﹤0.01% | 5107 |
|
|
2021
Q4 | $38K | Sell |
1,556
-206
| -12% | -$5.03K | ﹤0.01% | 5155 |
|
|
2021
Q3 | $69K | Sell |
1,762
-3,027
| -63% | -$119K | ﹤0.01% | 4860 |
|
|
2021
Q2 | $216K | Buy |
+4,789
| New | +$216K | ﹤0.01% | 4460 |
|